| 000 | 01468 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517154037.0 | ||
| 264 | 0 | _c20171109 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1097-6787 | ||
| 024 | 7 |
_a10.1016/j.jaad.2017.02.026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeber, Patrizia | |
| 245 | 0 | 0 |
_aApremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cJun 2017 |
||
| 300 |
_a1189-1191 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHidradenitis Suppurativa _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSampling Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSeyed Jafari, S Morteza | |
| 700 | 1 | _aYawalkar, Nikhil | |
| 700 | 1 | _aHunger, Robert E | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 76 _gno. 6 _gp. 1189-1191 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2017.02.026 _zAvailable from publisher's website |
| 999 |
_c27189068 _d27189068 |
||